Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,392 | 34,588 | 32,915 | 23,316 | 28,040 |
| Marketable Securities | 92,006 | 154,001 | 94,951 | 88,485 | 119,657 |
| TOTAL | $120,676 | $196,250 | $131,393 | $115,342 | $150,979 |
| Non-Current Assets | |||||
| PPE Net | 784 | 1,466 | 2,018 | 2,383 | 2,648 |
| Investments And Advances | 0 | 311 | 354 | 354 | 12,553 |
| Other Non-Current Assets | 1,722 | 2,820 | 5,430 | 5,462 | 3,183 |
| TOTAL | $2,506 | $4,597 | $7,802 | $8,199 | $18,384 |
| Total Assets | $123,182 | $200,847 | $139,195 | $123,541 | $169,363 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,502 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,530 | 1,166 | 2,544 | 2,394 | 3,069 |
| Accrued Expenses | 15,953 | 12,610 | 11,355 | 8,508 | 6,904 |
| TOTAL | $33,898 | $14,686 | $14,715 | $11,633 | $9,973 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,458 | 44,769 | 4,139 | 0 | N/A |
| Other Non-Current Liabilities | 0 | 913 | 1,947 | 2,640 | 1,287 |
| TOTAL | $31,458 | $45,682 | $6,086 | $2,640 | $1,287 |
| Total Liabilities | $65,356 | $60,368 | $20,801 | $14,273 | $11,260 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,240 | 61,772 | 43,720 | 23,673 | 23,464 |
| Common Shares | 6 | 6 | 4 | 2 | 2 |
| Retained earnings | -387,954 | -285,930 | -214,761 | -147,700 | -91,076 |
| Other shareholders' equity | 69 | 41 | -205 | 18 | 2 |
| TOTAL | $57,826 | $140,479 | $118,394 | $109,268 | $158,103 |
| Total Liabilities And Equity | $123,182 | $200,847 | $139,195 | $123,541 | $169,363 |